Find information on thousands of medical conditions and prescription drugs.

Acute intermittent porphyria

Acute intermittent porphyria (AIP) is a rare metabolic disorder that is characterized by a deficiency of the enzyme, porphobilinogen deaminase (PBG-D), also known as uroporphyrinogen I-synthase. This enzyme deficiency results in the accumulation of porphyrins or porphyrin precursors in the body. These are natural chemicals that normally do not accumulate in the body. This enzyme deficiency by itself is not sufficient to produce symptoms of the disease (latent). more...

Home
Diseases
A
Aagenaes syndrome
Aarskog Ose Pande syndrome
Aarskog syndrome
Aase Smith syndrome
Aase syndrome
ABCD syndrome
Abdallat Davis Farrage...
Abdominal aortic aneurysm
Abdominal cystic...
Abdominal defects
Ablutophobia
Absence of Gluteal muscle
Acalvaria
Acanthocheilonemiasis
Acanthocytosis
Acarophobia
Acatalasemia
Accessory pancreas
Achalasia
Achard syndrome
Achard-Thiers syndrome
Acheiropodia
Achondrogenesis
Achondrogenesis type 1A
Achondrogenesis type 1B
Achondroplasia
Achondroplastic dwarfism
Achromatopsia
Acid maltase deficiency
Ackerman syndrome
Acne
Acne rosacea
Acoustic neuroma
Acquired ichthyosis
Acquired syphilis
Acrofacial dysostosis,...
Acromegaly
Acrophobia
Acrospiroma
Actinomycosis
Activated protein C...
Acute febrile...
Acute intermittent porphyria
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Acute mountain sickness
Acute myelocytic leukemia
Acute myelogenous leukemia
Acute necrotizing...
Acute promyelocytic leukemia
Acute renal failure
Acute respiratory...
Acute tubular necrosis
Adams Nance syndrome
Adams-Oliver syndrome
Addison's disease
Adducted thumb syndrome...
Adenoid cystic carcinoma
Adenoma
Adenomyosis
Adenosine deaminase...
Adenosine monophosphate...
Adie syndrome
Adrenal incidentaloma
Adrenal insufficiency
Adrenocortical carcinoma
Adrenogenital syndrome
Adrenoleukodystrophy
Aerophobia
Agoraphobia
Agrizoophobia
Agyrophobia
Aicardi syndrome
Aichmophobia
AIDS
AIDS Dementia Complex
Ainhum
Albinism
Albright's hereditary...
Albuminurophobia
Alcaptonuria
Alcohol fetopathy
Alcoholic hepatitis
Alcoholic liver cirrhosis
Alektorophobia
Alexander disease
Alien hand syndrome
Alkaptonuria
Alliumphobia
Alopecia
Alopecia areata
Alopecia totalis
Alopecia universalis
Alpers disease
Alpha 1-antitrypsin...
Alpha-mannosidosis
Alport syndrome
Alternating hemiplegia
Alzheimer's disease
Amaurosis
Amblyopia
Ambras syndrome
Amelogenesis imperfecta
Amenorrhea
American trypanosomiasis
Amoebiasis
Amyloidosis
Amyotrophic lateral...
Anaphylaxis
Androgen insensitivity...
Anemia
Anemia, Diamond-Blackfan
Anemia, Pernicious
Anemia, Sideroblastic
Anemophobia
Anencephaly
Aneurysm
Aneurysm
Aneurysm of sinus of...
Angelman syndrome
Anguillulosis
Aniridia
Anisakiasis
Ankylosing spondylitis
Ankylostomiasis
Annular pancreas
Anorchidism
Anorexia nervosa
Anosmia
Anotia
Anthophobia
Anthrax disease
Antiphospholipid syndrome
Antisocial personality...
Antithrombin deficiency,...
Anton's syndrome
Aortic aneurysm
Aortic coarctation
Aortic dissection
Aortic valve stenosis
Apert syndrome
Aphthous stomatitis
Apiphobia
Aplastic anemia
Appendicitis
Apraxia
Arachnoiditis
Argininosuccinate...
Argininosuccinic aciduria
Argyria
Arnold-Chiari malformation
Arrhythmogenic right...
Arteriovenous malformation
Arteritis
Arthritis
Arthritis, Juvenile
Arthrogryposis
Arthrogryposis multiplex...
Asbestosis
Ascariasis
Aseptic meningitis
Asherman's syndrome
Aspartylglycosaminuria
Aspergillosis
Asphyxia neonatorum
Asthenia
Asthenia
Asthenophobia
Asthma
Astrocytoma
Ataxia telangiectasia
Atelectasis
Atelosteogenesis, type II
Atherosclerosis
Athetosis
Atopic Dermatitis
Atrial septal defect
Atrioventricular septal...
Atrophy
Attention Deficit...
Autoimmune hepatitis
Autoimmune...
Automysophobia
Autonomic dysfunction
Familial Alzheimer disease
Senescence
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Additional factors must also be present such as hormones, drugs and dietary changes that trigger the appearance of symptoms. Symptoms of AIP may include abdominal pain, constipation, and muscle weakness.

AIP is one of a group of disorders known as the porphyrias. The common feature in all porphyrias is the excess accumulation in the body of porphyrins or porphyrin precursors. Different types of porphyrias are characterized by the accumulation of different types of porphyrin chemicals.

Porphyrias can also be classified into two groups: the "hepatic" and "erythropoietic" types. In the hepatic types of porphyria, porphyrins and related substances originate in excess amounts from the liver; in the erythropoietic types, they originate mostly from the bone marrow.

The porphyrias with skin manifestations are sometimes called "cutaneous porphyrias." The "acute porphyrias" are characterized by sudden attacks of pain, especially abdominal pain, and other neurological symptoms. These acute symptoms may be severe and often rapidly appear. An individual may be considered latent if he or she has the characteristic enzyme deficiency but has never developed symptoms. There can be a wide spectrum of severity between the latent and active cases of any particular type of porphyria. The symptoms and treatments of the different types of porphyrias are not the same.

Read more at Wikipedia.org


[List your site here Free!]


Niacin, heme synthesis and porphyria - Letters to the Editor
From Townsend Letter for Doctors and Patients, 6/1/03

Editor:

The prize winning paper by Jonathon E. Prousky, ND, FRSH and Dugald Seely, BSc, ND (candidate) in the February/March 2003 issue entitled "The Case Report on the Successful Use of Inositol Hexaniacinate for the Treatment of Achiorhydria: Its Possible Mechanism of Action Upon the Central Nervous System and Parietal Cell-Adenosine Triphosphate-Dependent K+/H+ Pump" was most interesting. I would like to suggest an additional reason for the effectiveness of the high doses of niacin (1000 mg three times daily) that were used initially to treat the 39 year-old, 'well-nourished' patient. In the article, "Vitamin B-3 and Schizophrenia" by A. Hoffer, MD, PhD, FRCP(C) in the April 2001 issue, Dr. Hoffer explained that high doses of niacin change liver enzyme function, and that small elevations in liver enzyme tests were often seen with niacin therapy, but were no cause to discontinue the treatment. This change in liver enzyme activity would probably stimulate the production of much higher quantities of heme.

Heme is required for the synthesis of the P450 enzymes that are collectively responsible for the oxidation (and therefore the neutralization) of foreign chemicals, including drugs, pesticides and carcinogens. The P450 enzymes are also needed for the metabolism of adrenal hormones, fat soluble vitamins, fatty acids and for the synthesis of eicosanoids (so this includes the pro staglandins). (1,2) The correct balance and availability of adrenal hormones and also of eicosanoids control the flow of nutrients (including oxygen) into the cells. (3) Perhaps even more important, heme is needed for the production of red blood cells. (2) The consequent increase in the oxygen, and nutrient-carrying capacity of the blood, as well as the cell's renewed ability to receive the required nutrients, along with niacin's effect on the central nervous system and the parietal cells, fully restored the production of stomach acid in the 39 year-old patient.

However, the transformation of chemicals by the P450 enzymes can result in either increased or decreased toxicity, depending on the nutritional status and the toxicity of the patient. For example, low protein diets are associated with lower rates of drug metabolism. On the other hand, diets that are very low in carbohydrates deplete the necessary cofactors of P450 enzymes. (1) People with severe deficiencies from low stomach acidity and stress or toxicity are especially vulnerable when the liver and its enzymes are overtaxed. (1,2)

Very high doses of niacin (3,000 mg or more daily) can cause liver damage, diabetes, an inflamed stomach, eye damage and elevated levels of uric acid which can cause gout. The inositol hexaniacinate form of niacin is not known to cause any side effects, but nutritionally knowledgeable doctors advise that neither form of niacin be taken in large amounts without a nutritionally-oriented doctor's counsel. (4)

In addition, high doses of niacin can cause an acute attack in someone with porphyria, simply because niacin stimulates the production of heme. (5) The latter is produced by the pophyrin enzymes. Mutations or defects in the eight precursors of porphyrin enzymes cause the various inherited or acquired errors of metabolism in porphyria patients. Because heme can be produced in every cell, anything that triggers the production of heme to a larger extent can initiate a highly damaging, and often extremely painful, free-radical chain reaction that affects many organs and systems throughout the porphyria patient's body. (2) Not only the patient, but also all of his or her physicians need to know what to avoid, it is sometimes difficult and it can be impossible to avoid a porphyria attack, but every effort must be made; an acute hepatic porphyria attack may cause paralysis or can even kill the patient. (6,7)

The body responds differently to the various mutations. Different porphyrias (or mutations that lead to the tendency for porphyrins to accumulate throughout the body) need different treatments. It is essential that patients who may have porphyria receive the proper testing and interpretation of the tests, as well as the correct treatment, in as timely a manner as possible. (7) For more information please contact the American Porphyria Foundation, P.O. Box 22712, Houston, Texas 77227 USA. Their website is www.enterprise.net/apf. The website password <HOUSTON> ensures ready access for physicians.

Judy Kitchen

3637 Serra Road

Malibu, California 90265 USA

Phone/Fax 310-456-6837

References

(1.) Guengerich, Peter K, Influence of nutrients and other dietary materials on cytechrome P-450 enzymes, Department of Biochemistry and center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, TN 37232-0146 or American Journal of Clinical Nutrition 1996; 61 (supplement) 651S-8S.

(2.) Wilson, cynthia, chemical Intolerance: Hallmark Feature of MCS and Porphyria, Our Toxic Times, chemical Injury Information Network, MT, October 1996.

(3.) Murray, Michael T., ND, Encyclopedia of Nutritional Supplements; Prima Publishing, CA 1996.

(4.) Lininger, Schuyler W., Jr., DC, Gaby, Alan R., MD, Austin, Steve, ND, Drown, Donald J., ND, Wright, Jonathan V., MD, Duncan, Alice, DC, CCH, The Natural Pharmacy, Prima Publishing 1099.

(5.) Wilson, Cynthia, Porphyrinogenic Substances, Chemical Injury Information Network, MT. 406-5472255.

(6.) Ridley, Alan, The Neuropathy of Acute Intermittent Porphyria, Quarterly Journal of Medicine News Series XXXVIII, No. 151, July 1969.

(7.) Porphyria News, American Porphyria Foundation, Texas, Spring 2003.

COPYRIGHT 2003 The Townsend Letter Group
COPYRIGHT 2003 Gale Group

Return to Acute intermittent porphyria
Home Contact Resources Exchange Links ebay